◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

EDWARDS LIFESCIENCES CORP

CIK: 1099800 SIC: 3842
$6.07B
Revenue
$1.07B
Net Income
78.01%
Gross Margin
20.84%
Op. Margin
$2.02B
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 7 of 47 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
+ Total Revenue $1.57B $1.55B $1.53B $1.41B $1.39B $1.35B $1.39B
Revenue Growth % (YoY) 13.3% 14.7% 10.6% nan% nan% nan% nan%
Cost of Revenue $343.00M $345.20M $344.40M $301.60M $292.20M $262.90M $285.30M
+ Gross Profit $1.23B $1.21B $1.19B $1.11B $1.09B $1.09B $1.10B
Gross Margin % 78.1% 77.8% 77.5% 78.7% 78.9% 80.6% 79.4%
Research & Development $267.70M $280.70M $276.20M $254.60M $271.10M $253.40M $272.60M
Selling General & Admin $602.90M $514.60M $502.00M $465.70M $491.90M $421.40M $450.80M
+ Operating Income $151.10M $307.10M $411.20M $394.80M $312.60M $350.60M $369.10M
Operating Margin % 9.6% 19.8% 26.8% 27.9% 22.6% 25.9% 26.6%
Other Income/Expense $3.20M $2.70M $-1.30M $2.60M $33.30M $27.90M $2.00M
Income Before Tax $90.40M $348.40M $400.20M $433.90M $390.10M $402.80M $386.60M
Income Tax Expense $26.20M $56.10M $64.30M $70.30M $45.10M $40.70M $20.20M
+ Net Income $91.20M $291.10M $333.20M $358.00M $385.60M $3.07B $366.30M
Net Margin % 5.8% 18.7% 21.7% 25.3% 27.8% 226.7% 26.4%
Basic EPS 0.16 0.50 0.57 0.61 0.67 5.14 0.61
Diluted EPS 0.16 0.50 0.56 0.61 0.68 5.13 0.61
Basic Shares Outstanding - 584.7M 587.0M 586.9M -2.6M 597.2M 602.1M
Diluted Shares Outstanding - 585.7M 587.9M 587.8M -2.9M 598.1M 604.3M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Cash & Cash Equivalents $2.94B $2.69B $3.27B $3.14B $3.05B $3.68B $1.64B
Short-term Investments $1.29B $1.16B $789.40M $757.90M $930.70M $769.70M $345.30M
Accounts Receivable $659.60M $693.30M $697.00M $669.20M $609.10M $716.00M $778.30M
Inventory $1.13B $1.14B $1.14B $1.11B $1.09B $1.10B $1.02B
Other Current Assets $339.30M $323.40M $314.40M $304.50M $347.60M $231.00M $252.10M
Total Current Assets $6.74B $6.36B $6.58B $6.21B $6.29B $6.73B $4.52B
Property Plant & Equipment $1.81B $1.74B $1.73B $1.70B $1.69B $1.68B $1.64B
Goodwill $1.77B $1.77B $1.78B $1.78B $1.78B $1.61B $1.15B
Intangible Assets $1.13B $1.13B $1.17B $1.17B $1.18B $956.10M $417.10M
Long-term Investments $278.60M $274.70M $298.50M $277.90M $307.90M $319.60M $353.30M
Other Non-current Assets $730.20M $784.80M $743.00M $742.70M $721.60M $683.50M $789.80M
Total Assets $13.70B $13.27B $13.49B $13.02B $13.06B $12.97B $10.10B
Accounts Payable $227.50M $165.00M $162.10M $172.40M $197.40M $172.80M $185.90M
Total Current Liabilities $1.81B $1.59B $1.40B $1.39B $1.51B $1.94B $1.22B
Long-term Debt $598.30M $598.20M $598.00M $597.80M $597.70M $597.50M $597.30M
Other Non-current Liabilities $362.30M $362.60M $379.20M $357.60M $357.50M $322.60M $257.10M
Total Liabilities $3.36B $3.07B $2.88B $2.83B $2.99B $3.36B $2.59B
Common Stock $658.70M $658.20M $657.60M $655.90M $654.80M $654.30M $653.50M
Retained Earnings $14.24B $14.15B $13.86B $13.53B $13.17B $12.78B $9.71B
Total Stockholders Equity $10.34B $10.21B $10.55B $10.13B $10.00B $9.55B $7.44B
Total Liabilities & Equity $13.70B $13.27B $13.49B $13.02B $13.06B $12.97B $10.10B
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Net Income $91.20M $291.10M $691.20M $358.00M $385.60M $3.07B $366.30M
Depreciation & Amortization $42.70M $113.90M $74.70M $36.60M $42.60M $112.60M $78.10M
Stock-based Compensation $39.20M $118.90M $77.70M $40.20M $31.70M $130.60M $88.50M
Change in Inventory $-11.00M $-39.70M $-41.50M $100.00K $51.20M $204.90M $163.70M
Operating Cash Flow $450.90M $1.14B $570.60M $280.40M $-127.50M $669.80M $318.00M
Capital Expenditure $97.40M $162.80M $105.30M $56.00M $49.80M $202.60M $150.70M
Investing Cash Flow $-198.30M $-514.60M $-86.80M $85.30M $-576.70M $2.89B $187.90M
Stock Repurchased $40.60M $852.80M $264.10M $258.60M $100.10M $1.06B $158.30M
Financing Cash Flow $-11.40M $-945.40M $-205.30M $-258.00M $28.60M $-1.01B $-34.90M
Net Change in Cash $244.70M $-364.00M $231.20M $90.00M $-624.60M $2.54B $510.10M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $1.55B - $4.50B -
Cost of Revenue $345.20M - $991.20M -
Gross Profit $1.21B - $3.51B -
Research & Development $280.70M - $811.50M -
Selling General & Admin $514.60M - $1.48B -
Operating Income $307.10M - $1.11B -
Other Income/Expense $2.70M - $4.00M -
Income Before Tax $348.40M - $1.18B -
Income Tax Expense $56.10M - $190.70M -
Net Income $291.10M $365.00M $982.30M -
Basic EPS 0.50 - 1.68 -
Diluted EPS 0.50 - 1.67 -
Basic Shares Outstanding $584.70M - $586.20M -
Diluted Shares Outstanding $585.70M - $587.20M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $2.69B $3.05B
Short-term Investments $1.16B $930.70M
Accounts Receivable $693.30M $609.10M
Inventory $1.14B $1.09B
Other Current Assets $323.40M $347.60M
Total Current Assets $6.36B $6.29B
Property Plant & Equipment $1.74B $1.69B
Goodwill $1.77B $1.78B
Intangible Assets $1.13B $1.18B
Long-term Investments $274.70M $307.90M
Other Non-current Assets $784.80M $721.60M
Total Assets $13.27B $13.06B
Accounts Payable $165.00M $197.40M
Total Current Liabilities $1.59B $1.51B
Long-term Debt $598.20M $597.70M
Other Non-current Liabilities $362.60M $426.00M
Total Liabilities $3.07B $2.99B
Common Stock $658.20M $654.80M
Retained Earnings $14.15B $13.17B
Total Stockholders Equity $10.21B $10.00B
Total Liabilities & Equity $13.27B $13.06B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $291.10M $365.00M $982.30M -
Depreciation & Amortization - - $113.90M -
Stock-based Compensation - - $118.90M -
Change in Inventory - - $-39.70M -
Operating Cash Flow - - $1.14B -
Capital Expenditure - - $162.80M -
Investing Cash Flow - - $-514.60M -
Stock Repurchased - - $852.80M -
Financing Cash Flow - - $-945.40M -
Net Change in Cash - - $-364.00M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...